Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Exploring the role of upfront autoSCT in multiple myeloma

Meral Beksac, MD, Istinye University Ankara Liv Hospital, Ankara, Turkey, discusses a recently published review exploring the benefits and drawbacks of deferring autologous stem cell transplantation (autoSCT) in patients with multiple myeloma, highlighting findings from ongoing clinical trials and the impact of novel regimens. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.